Skip to main content

MACQUARIE GROUP LTD

Position in NBIX — Neurocrine Biosciences Inc

CIK 1418333 Sydney, NSW 2000, C3

Position in NBIX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,337,649
+$779,692 QoQ
Shares Held
13,870
+17.3% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#292
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 59% Shared 41% None 0%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

MACQUARIE GROUP LTD holds $49,746,703 across 12 Drug Manufacturers - Specialty & Generic names. NBIX ranks #4 (4.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
4 NBIX
Neurocrine Biosciences Inc
This page
13,870 $2,337,649

All Filings in NBIX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,337,649 13,870
2026-03-31 $1,557,957 11,826
2025-12-31 $1,562,966 11,020
2025-09-30 $44,284,555 315,462
2025-06-30 $33,999,395 270,502
2025-03-31 $25,587,088 231,348
2024-12-31 $37,418,199 274,126
2024-09-30 $56,710,131 492,190
2024-06-30 $37,305,402 270,977
2024-03-31 $38,067,298 276,010
2023-12-31 $43,234,276 328,129
2023-09-30 $29,093,737 258,611
2023-06-30 $24,463,965 259,427
2023-03-31 $29,617,982 292,610
2022-12-31 $34,077,902 285,314
2022-09-30 $30,408,347 286,304
2022-06-30 $28,550,915 292,890
2022-03-31 $29,818,405 318,063
2021-12-31 $21,527,653 252,761
2021-09-30 $22,451,091 234,085
2021-06-30 $23,011,897 236,456
2021-03-31 $22,246,617 228,757
2020-12-31 $22,193,108 231,540
2020-09-30 $91,365,558 950,141
2020-06-30 $111,338,298 912,609
2020-03-31 $20,360,368 235,244